Free of charge | Open to everyone
10:00 Eastern Time (ET) – 16:00 Central European Summer Time (CEST)
Tuesday 25 August Wave Life Sciences is planning to share exciting updates on their platform, including advances in oligonucleotide chemistry in the upcoming Analyst & Investor Research Webcast.
In a recent press release, the company also announced that the results of their huntingtin lowering trials is expected in the first quarter of 2021. Learn more about their study here.